Overexpression of optineurin E50K disrupts Rab8 interaction and leads to a progressive retinal degeneration in mice
Open accessThe DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
Abstract
Glaucoma is one of the leading causes of bilateral blindness affecting nearly 8 million people worldwide. Glaucoma is characterized by a progressive loss of retinal ganglion cells (RGCs) and is often associated with elevated intraocular pressure (IOP). However, patients with normal tension glaucoma (NTG), a subtype of primary open-angle glaucoma (POAG), develop the disease without IOP elevation. The molecular pathways leading to the pathology of NTG and POAG are still unclear. Here, we describe the phenotypic characteristics of transgenic mice overexpressing wild-type (Wt) or mutated optineurin (Optn). Mutations E50K, H486R and Optn with a deletion of the first (amino acids 153-174) or second (amino acids 426-461) leucine zipper were used for overexpression. After 16 months, histological abnormalities were exclusively observed in the retina of E50K mutant mice with loss of RGCs and connecting synapses in the peripheral retina leading to a thinning of the nerve fiber layer at the optic nerve head at normal IOP. E50K mice also showed massive apoptosis and degeneration of entire retina, leading to approximately a 28% reduction of the retina thickness. At the molecular level, introduction of the E50K mutation disrupts the interaction between Optn and Rab8 GTPase, a protein involved in the regulation of vesicle transport from Golgi to plasma membrane. Wt Optn and an active GTP-bound form of Rab8 complex were localized at the Golgi complex. These data suggest that alternation of the Optn sequence can initiate significant retinal degeneration in mice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Transgenic mice overexpressing the OPTNE50K mutation, which instigates the formation of insoluble OPTN aggregates and results in autophagy blockade, display RGC loss and reduced retinal thickness (Chi et al, 2010; Minegishi et al, 2013).”
From Autophagy in major human diseases (2021) · cites this paper as Chi et al, 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The number of people with glaucoma worldwide in 2010 and 2020
Quigley, H. A. (2006) · British Journal of Ophthalmology · doi:10.1136/bjo.2005.081224 · Cited by 7,394
Rab proteins as membrane organizers
Zerial, M., & McBride, H. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35052055 · Cited by 3,381 · cited 1×
“Rab GTPases regulate all stages of membrane trafficking, including vesicle transport, cargo sorting, transport, tethering and fusion (32).”
Number of people with glaucoma worldwide.
Quigley, H. A. (1996) · British Journal of Ophthalmology · doi:10.1136/bjo.80.5.389 · Cited by 2,998
The definition and classification of glaucoma in prevalence surveys
Foster, P. J. (2002) · British Journal of Ophthalmology · doi:10.1136/bjo.86.2.238 · Cited by 2,365 · cited 1×
“In general, glaucoma most often affects peripheral visual field at early stages of the disease, whereas deterioration of the central retina can be seen only at later stages of the disease (31).”
Identification of a Gene That Causes Primary Open Angle Glaucoma
Stone, E. M., Fingert, J. H., Alward, W. L. M., Nguyen, T. D., Polansky, J. R., Sunden, S. L. F., Nishimura, D., Clark, A. F., Nystuen, A., Nichols, B. E., et al. (1997) · Science · doi:10.1126/science.275.5300.668 · Cited by 1,433 · cited 2×
“The H486R mutation is reportedly associated with both NTG and JOAG (4,26).”
Nachury, M. V., Loktev, A. V., Zhang, Q., Westlake, C. J., Peränen, J., Merdes, A., Slusarski, D. C., Scheller, R. H., Bazan, J. F., Sheffield, V. C., et al. (2007) · Cell · doi:10.1016/j.cell.2007.03.053 · Cited by 1,384 · cited 1×
“In the photoreceptor, Rab8 has a pivotal role of docking and fusion in rhodopsin trafficking (36) and cooperating with Bardet–Biedl syndrome proteins in ciliary membrane biogenesis (37,38).”
Adult-Onset Primary Open-Angle Glaucoma Caused by Mutations in Optineurin
Rezaie, T., Child, A., Hitchings, R., Brice, G., Miller, L., Coca-Prados, M., Héon, E., Krupin, T., Ritch, R., Kreutzer, D., et al. (2002) · Science · doi:10.1126/science.1066901 · Cited by 1,105 · cited 3×
“E50K, a substitution of glutamic acid by lysine at amino acid 50, is exclusively associated with the familial and sporadic forms of NTG (6,8,11), and that phenotype is, on an average, more severe compared with NTG without the E50K mutation (Supplementary Material) (6).”
The prevalence of primary open-angle glaucoma in Japanese
Iwase, A., Suzuki, Y., Araie, M., Yamamoto, T., Abe, H., Shirato, S., Kuwayama, Y., Mishima, H. K., Shimizu, H., Tomita, G., et al. (2004) · Ophthalmology · doi:10.1016/j.ophtha.2004.03.029 · Cited by 872
Self-citationStoilov, I. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.4.641 · Cited by 647
Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice.
John, S. W. M., Smith, R. S., Savinova, O. V., Hawes, N. L., Chang, B., Turnbull, D., Davisson, M. T., Roderick, T. H., & Heckenlively, J. R. (1998) · PubMed · Cited by 603
Cited by
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
Autophagy in major human diseases
Klionsky, D. J., Petroni, G., Amaravadi, R. K., Baehrecke, E. H., Ballabio, A., Boya, P., Bravo‐San Pedro, J. M., Cadwell, K., Cecconi, F., Choi, A. M. K., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2021108863 · Cited by 1,585
Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles
Galluzzi, L., Bravo-San Pedro, J. M., Levine, B., Green, D. R., & Kroemer, G. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.22 · Cited by 842
Shim, M. S., Takihara, Y., Kim, K.-Y., Iwata, T., Yue, B. Y. J. T., Inatani, M., Weinreb, R. N., Perkins, G. A., & Ju, W.-K. (2017) · Scientific Reports · doi:10.1038/srep40460 · Cited by 285
Self-citationAutophagy in the eye: Development, degeneration, and aging
Boya, P., Esteban-Martínez, L., Serrano-Puebla, A., Gómez-Sintes, R., & Villarejo-Zori, B. (2016) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2016.08.001 · Cited by 231
Primary open-angle glaucoma genes
Fingert, J. H. (2011) · Eye · doi:10.1038/eye.2011.97 · Cited by 209
Janssen, S. F., Gorgels, T. G. M. F., Ramdas, W. D., Klaver, C. C. W., van Duijn, C. M., Jansonius, N. M., & Bergen, A. A. B. (2013) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.09.001 · Cited by 185
Nanotherapies for the treatment of ocular diseases
Reimondez-Troitiño, S., Csaba, N., Alonso, M. J., & de la Fuente, M. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.02.019 · Cited by 182
Major review: Molecular genetics of primary open-angle glaucoma
Liu, Y., & Allingham, R. R. (2017) · Experimental Eye Research · doi:10.1016/j.exer.2017.05.002 · Cited by 167
Glaucoma: genes, phenotypes, and new directions for therapy
Fan, B., & Wiggs, J. L. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43085 · Cited by 163
“The role of OPTN in ganglion cell loss is supported by studies showing that overexpression of the optineurin E50K mutation in mice causes loss of ganglion cells without elevation of IOP (90).”
Cellular and Molecular Biology of Optineurin
(2012) · International Review of Cell and Molecular Biology · doi:10.1016/b978-0-12-394305-7.00005-7 · Cited by 122
“In addition to the genetic link, a causal role of E50K in glaucoma is also implicated by a recent study of Chi et al. (2010) that loss of RGCs, reduction of retinal thickness, and excavation of the optic nerve head are observed in E50K-expressing normal tension transgenic mice.”
BackgroundEmerging views of OPTN (optineurin) function in the autophagic process associated with disease
Qiu, Y., Wang, J., Li, H., Yang, B., Wang, J., He, Q., & Weng, Q. (2022) · Autophagy · doi:10.1080/15548627.2021.1908722 · Cited by 134
Molecular genetics in glaucoma
Liu, Y., & Allingham, R. R. (2011) · Experimental Eye Research · doi:10.1016/j.exer.2011.08.007 · Cited by 146
“Transgenic mice with theE50Kmutationdevelop apoptosis and retinal degenerationwhich reduces retinal thickness by approximately 28% (Chi et al., 2010a).”
BackgroundOptineurin: A Coordinator of Membrane-Associated Cargo Trafficking and Autophagy
Ryan, T. A., & Tumbarello, D. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01024 · Cited by 146
“Although optineurin interacts with Rab8 and Htt at the Golgi (26), a localisation that is disrupted by mutant Htt resulting in lysosomal impairment (71), and is found in Htt protein inclusions observed in the cortex of Huntington’s patients (229), it is currently not known what role optineurin plays in the progression…”
BackgroundMethodInfluentialNormal‑tension glaucoma: Pathogenesis and genetics (Review)
Trivli, A., Koliarakis, I., Terzidou, C., Goulielmos, G. N., Siganos, C. S., Spandidos, D. A., Dalianis, G., & Detorakis, Ε. T. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.7011 · Cited by 140
“E50K mutant transgenic mice overexpressing OPTN have demonstrated RGC loss, also reflecting the role of oxidative stress in NTG (118).”
Minegishi, Y., Iejima, D., Kobayashi, H., Chi, Z.-L., Kawase, K., Yamamoto, T., Seki, T., Yuasa, S., Fukuda, K., & Iwata, T. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt210 · Cited by 138
Self-citationAutophagy in the eye: implications for ocular cell health.
Frost, L. S., Mitchell, C. H., & Boesze-Battaglia, K. (2014) · Experimental Eye Research · doi:10.1016/j.exer.2014.04.010 · Cited by 134
“E50K is themost common disease causing mutation of optineurin (Chalasani et al., 2007), and overexpression of the optineurin E50K mutation in mice led to a loss of RGCs and other retinal cell types with no change in IOP (Chi et al., 2010).”
InfluentialLi, F., Xie, X., Wang, Y., Liu, J., Cheng, X., Guo, Y., Gong, Y., Hu, S., & Pan, L. (2016) · Nature Communications · doi:10.1038/ncomms12708 · Cited by 126
“Among the OPTN mutations, the glaucoma-associated E50K mutation is demonstrated to associate with a more progressive and severe disease phenotype, and causes death of retinal ganglion cells in transgenic mice 31,32 .”
Significance of optineurin mutations in glaucoma and other diseases
Minegishi, Y., Nakayama, M., Iejima, D., Kawase, K., & Iwata, T. (2016) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2016.08.002 · Cited by 126
Self-citationOhlemacher, S. K., Sridhar, A., Xiao, Y., Hochstetler, A. E., Sarfarazi, M., Cummins, T. R., & Meyer, J. S. (2016) · Stem Cells · doi:10.1002/stem.2356 · Cited by 123
Optineurin Is Required for CYLD-Dependent Inhibition of TNFα-Induced NF-κB Activation
Nagabhushana, A., Bansal, M., & Swarup, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017477 · Cited by 111
Rab8 GTPase as a regulator of cell shape
Peränen, J. (2011) · Cytoskeleton · doi:10.1002/cm.20529 · Cited by 108
“This mutation interferes with the interaction of optineurin with Rab8, and leads to progressive retinal degeneration in mice [Chi et al., 2010].”
BackgroundDysfunction of Optineurin in Amyotrophic Lateral Sclerosis and Glaucoma
Toth, R. P., & Atkin, J. D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01017 · Cited by 114
“The important role of optineurin in vesicular trafficking in complex with myosin VI and Rab8 is now well established (Figure 4).”
BackgroundInfluentialAddressing neurodegeneration in glaucoma: Mechanisms, challenges, and treatments
Ghanem, G. O. B., Wareham, L. K., & Calkins, D. J. (2024) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2024.101261 · Cited by 112
“This model, representing NTG, demonstrates RGC degeneration in the peripheral retina at normal IOP levels via the disruption of vesicle transport from the Golgi to the plasma membrane (Chi et al., 2010).”
Optineurin: The autophagy connection
Ying, H., & Yue, B. Y. J. T. (2016) · Experimental Eye Research · doi:10.1016/j.exer.2015.06.029 · Cited by 97
“The level of PSMB5 and LC3 was examined on the retinal slides of E50K transgenic mice in which E50K optineurin was overexpressed under the CMV early enhancer/chicken βactin promoter (Chi et al., 2010).”
InfluentialA Tucker, B. (2014) · Journal of Stem Cell Research & Therapy · doi:10.4172/2157-7633.1000161 · Cited by 98
“Similar studies of OPTN-related glaucoma with transgenic mice are also underway [24,36].”
BackgroundWeil, R., Laplantine, E., Curic, S., & Génin, P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01243 · Cited by 81
“However, the molecular mechanisms by which the M98K or E50K-Optn mutant enhances and blocks autophagy, respectively, are not clear.”
BackgroundInfluentialCellular functions of optineurin in health and disease
Slowicka, K., Vereecke, L., & van Loo, G. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.07.002 · Cited by 96
Muench, N. A., Patel, S., Maes, M. E., Donahue, R., Ikeda, A., & Nickells, R. W. (2021) · Cells · doi:10.3390/cells10071593 · Cited by 102
Mi, X.-S., Qian, F., Lo, A., Chang, R. C., Lin, B., Chung, S. K., & So, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045469 · Cited by 102
“1 mm on both sides from the optic nerve head [33] were analyzed using StereoInvestigatorH software (MBF BioscienceMicroBrightField Inc).”
MethodAqueous Humor Outflow: Dynamics and Disease
Chowdhury, U. R., Hann, C. R., Stamer, W. D., & Fautsch, M. P. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-16744 · Cited by 102
“For example, 90% of Asian populations suffering from POAG have IOP in the normal range in comparison to Caucasians, whose numbers range from 30% to 50%.6 In any case, effectively lowering IOP is neuroprotective, slowing or stopping vision loss in glaucoma patients, even if they do not have elevated IOP.”
InfluentialToward an integrative view of Optineurin functions
Kachaner, D., Génin, P., Laplantine, E., & Weil, R. (2012) · Cell Cycle · doi:10.4161/cc.20946 · Cited by 99
Sirohi, K., Chalasani, M. L. S., Sudhakar, C., Kumari, A., Radha, V., & Swarup, G. (2013) · Autophagy · doi:10.4161/auto.23458 · Cited by 91
Retinal ganglion cell apoptotic pathway in glaucoma
Levkovitch-Verbin, H. (2015) · Progress in brain research · doi:10.1016/bs.pbr.2015.05.005 · Cited by 97
Sayyad, Z., Sirohi, K., Radha, V., & Swarup, G. (2017) · Scientific Reports · doi:10.1038/s41598-017-17241-0 · Cited by 96
Optineurin suppression causes neuronal cell death via NF‐κB pathway
Akizuki, M., Yamashita, H., Uemura, K., Maruyama, H., Kawakami, H., Ito, H., & Takahashi, R. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12326 · Cited by 96
Processing of Optineurin in Neuronal Cells
Shen, X., Ying, H., Qiu, Y., Park, J.-S., Shyam, R., Chi, Z.-L., Iwata, T., & Yue, B. Y. J. T. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.175810 · Cited by 88
Self-citationCopy Number Variations of TBK1 in Australian Patients With Primary Open-Angle Glaucoma
Awadalla, M. S., Fingert, J. H., Roos, B. E., Chen, S., Holmes, R., Graham, S. L., Chehade, M., Galanopolous, A., Ridge, B., Souzeau, E., et al. (2015) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2014.09.044 · Cited by 82
Using genetic mouse models to gain insight into glaucoma: Past results and future possibilities
Fernandes, K. A., Harder, J. M., Williams, P. A., Rausch, R. L., Kiernan, A. E., Nair, K. S., Anderson, M. G., John, S. W. M., Howell, G. R., & Libby, R. T. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2015.06.019 · Cited by 91
“…that have been designed to either create an orthologous mutation to that found in ouse models to gain insight into glaucoma: Past results and future /j.exer.2015.06.019 human glaucoma patients or to disrupt molecular function in a region of the gene with an orthologous mutation (Chi et al., 2010b).”
BackgroundInfluentialNMDA receptor subunits have different roles in NMDA-induced neurotoxicity in the retina
Bai, N., Aida, T., Yanagisawa, M., Katou, S., Sakimura, K., Mishina, M., & Tanaka, K. (2013) · Molecular Brain · doi:10.1186/1756-6606-6-34 · Cited by 85
“Eyes from mice at postnatal day 35 (P35) were enucleated and fixed in Davidson’s solution fixative [43], then embedded in paraffin wax.”
MethodShim, M. S., Takihara, Y., Kim, K.-Y., Iwata, T., Yue, B. Y. J. T., Inatani, M., Weinreb, R. N., Perkins, G. A., & Ju, W.-K. (2016) · Scientific Reports · doi:10.1038/srep33830 · Cited by 72
Self-citationMicroRNAs in glaucoma and neurodegenerative diseases
Molasy, M., Walczak, A., Szaflik, J., Szaflik, J. P., & Majsterek, I. (2016) · Journal of Human Genetics · doi:10.1038/jhg.2016.91 · Cited by 78
Altered Functions and Interactions of Glaucoma-Associated Mutants of Optineurin
Swarup, G., & Sayyad, Z. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01287 · Cited by 69
“This was seen in yeast two-hybrid assay, which measures direct interaction and also by a fluorescence based assay in mammalian cells (37, 77).”
BackgroundMethodConsequences of Rab GTPase dysfunction in genetic or acquired human diseases
Banworth, M. J., & Li, G. (2017) · Small GTPases · doi:10.1080/21541248.2017.1397833 · Cited by 77
“Rab8a secretory vesicles/exocytosis Parkinson’s disease, Lowe syndrome and retinal degeneration [253-257]”
BackgroundMendelian genes in primary open angle glaucoma
Sears, N. C., Boese, E. A., Miller, M., & Fingert, J. H. (2019) · Experimental Eye Research · doi:10.1016/j.exer.2019.107702 · Cited by 77
Chalasani, M. L. S., Kumari, A., Radha, V., & Swarup, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095758 · Cited by 64
“Studies carried out by Chi et al have further revealed that E50K transgenic mice show severe retinal degeneration where all the retinal cell layers are affected [27].”
BackgroundInfluentialOptineurin mediates negative regulation of Rab8 function by TBC1D17, a GTPase activating protein
Vaibhava, V., Nagabhushana, A., Chalasani, M. L. S., Sudhakar, C., Kumari, A., & Swarup, G. (2012) · Journal of Cell Science · doi:10.1242/jcs.102327 · Cited by 59
“This loss of direct interaction between the E50K mutant and Rab8 has also been shown in mammalian cells (Chi et al., 2010).”
BackgroundThe current research status of normal tension glaucoma
Mi, X.-S., Yuan, T., & So, K. (2014) · Clinical Interventions in Aging · doi:10.2147/cia.s67263 · Cited by 70
“Correspondingly, the transgenic mice with over-expression of OPTN (containing E50K point mutants) showed significant retinal degeneration.(22) OPA1 is another reported human NTG-causing gene.”
Kryndushkin, D. S., Ihrke, G., Piermartiri, T., & Shewmaker, F. P. (2012) · Molecular Microbiology · doi:10.1111/mmi.12075 · Cited by 69
“3C), consistent with the behaviour of this mutant in the reported cell culture and mouse models (Park et al., 2006; 2010; Chi et al., 2010; Meng et al., 2012).”
BackgroundTranslational Preclinical Pharmacologic Disease Models for Ophthalmic Drug Development
Shah, M., Cabrera-Ghayouri, S., Christie, L., Held, K. S., & Viswanath, V. (2019) · Pharmaceutical Research · doi:10.1007/s11095-019-2588-5 · Cited by 68
Chew, T. S., O'Shea, N. R., Sewell, G. W., Oehlers, S. H., Mulvey, C. M., Crosier, P. S., Godovac-Zimmermann, J., Bloom, S. L., Smith, A. M., & Segal, A. W. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.020362 · Cited by 53
“Mice overexpressing E50K-OPTN have thinner retinas with loss of retinal ganglion cells (RGCs) (Chi et al., 2010) and impaired postGolgi trafficking in human retinal pigment epithelium and RGCs.”
Harada, C., Kimura, A. K., Guo, X., Namekata, K., & Harada, T. (2018) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2018-312724 · Cited by 65
Visual impairment in an optineurin mouse model of primary open-angle glaucoma
Tseng, H. C., Riday, T. T., McKee, C., Braine, C. E., Bomze, H., Barak, I., Marean-Reardon, C., John, S. W. M., Philpot, B. D., & Ehlers, M. D. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.02.012 · Cited by 60
“In contrast to OPTN mice in previous reports, no diffuse thinning of non-GCL layers was found (Chi et al., 2010; Meng et al., 2012).”
RAB GTPases and RAB-interacting proteins and their role in the control of cognitive functions
D’Adamo, P., Masetti, M., Bianchi, V., Morè, L., Mignogna, M. L., Giannandrea, M., & Gatti, S. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.12.009 · Cited by 61
Weishaupt, J. H., Waibel, S., Birve, A., Volk, A. E., Mayer, B., Meyer, T., Ludolph, A. C., & Andersen, P. M. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.09.007 · Cited by 57
“In line with this seemingly polytopic function of optineurin it plays a role in diverse cell biological functions (e.g., membrane and vesicular trafficking, transcription activation, and nuclear factor kB [Nf-kB] signaling; Chi et al., 2010; reviewed in Ying and Yue, 2012).”
BackgroundGenetics of primary open angle glaucoma
Takamoto, M., & Araie, M. (2013) · Japanese Journal of Ophthalmology · doi:10.1007/s10384-013-0286-0 · Cited by 56
“Optineurin (OPTN) Oxidative stress [95], the mitochondrial caspase-dependent cell death pathway [96], disruption of OPTN–Rab8 interaction and protein trafficking [85], Golgi body deformation and deteriorates intracellular traffic [197], secretory vesicle transport and decrease the release of the neurotrophic factor [1…”
BackgroundDefects in autophagy caused by glaucoma-associated mutations in optineurin
Sirohi, K., & Swarup, G. (2016) · Experimental Eye Research · doi:10.1016/j.exer.2015.08.020 · Cited by 50
Sirohi, K., Kumari, A., Radha, V., & Swarup, G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138289 · Cited by 52
“Deleterious effects of E50K-OPTNmutant on retinal ganglion cells as well as on other retinal cells was also seen in E50K transgenic mice [32] suggesting the usefulness of this cell culture model [33].”
BackgroundChi, Z., Yasumoto, F., Sergeev, Y. V., MINAMI, M., Obazawa, M., Kimura, I., Takada, Y., & Iwata, T. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq299 · Cited by 51
Self-citationDock3 interaction with a glutamate-receptor NR2D subunit protects neurons from excitotoxicity
Bai, N., Hayashi, H., Aida, T., Namekata, K., Harada, T., Mishina, M., & Tanaka, K. (2013) · Molecular Brain · doi:10.1186/1756-6606-6-22 · Cited by 49
“Eyes from mice at postnatal day 35 (P35) were enucleated, fixed in Davidson’s solution fixative [41] overnight at 4°C, and dehydrated in 70% ethanol for three days at 4°C.”
MethodZhang, S., Shao, Z., Liu, X., Hou, M., Cheng, F., Lei, D., & Yuan, H. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00432-0 · Cited by 50
Gao, J., Ohtsubo, M., Hotta, Y., & Minoshima, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101206 · Cited by 48
“Those functions are always fulfilled by the interaction with optineurin-binding proteins, including polyubiqutinated receptor-interacting protein (polyUb RIP) [15], deubiquitinase CYLD [25], Rab8 [17,26,27], huntingtin [26], myosin VI [17], transferrin receptor (TfR) [19], metabotropic glutamate receptor [21], TANK-bi…”
BackgroundSippl, C., Bosserhoff, A., Fischer, D., & Tamm, E. R. (2011) · Experimental Eye Research · doi:10.1016/j.exer.2011.08.011 · Cited by 47
“Moreover, forced overexpression of E50K optineurin in transgenic mice, which leads to retinal degeneration, is accompanied by a disruption of the interaction between optineurin and Rab8 which appears to be critical for the role of optineurin in vesicular transport (Chi et al., 2010).”
BackgroundThe role of autophagy in axonal degeneration of the optic nerve
Koch, J. C., & Lingor, P. (2016) · Experimental Eye Research · doi:10.1016/j.exer.2015.08.016 · Cited by 46
Walking through trabecular meshwork biology: Toward engineering design of outflow physiology
Dautriche, C. N., Xie, Y., & Sharfstein, S. T. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2014.04.012 · Cited by 46
A critical role of Hrd1 in the regulation of optineurin degradation and aggresome formation
Mao, J., Qin, X., Liu, C., Ying, Z., Wang, H., & Wang, G. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx096 · Cited by 44
Translational models of ocular disease
Zeiss, C. J. (2013) · Veterinary Ophthalmology · doi:10.1111/vop.12065 · Cited by 44
Esseltine, J. L., Ribeiro, F. M., & Ferguson, S. S. G. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0625-12.2012 · Cited by 43
“Mice expressing this mutant form of OPTN, which no longer associates with Rab8, develop gross histological abnormalities including massive retinal apoptosis, loss of retinal ganglion cells and connecting synapses in the retina, resulting in dramatic thinning of the retina (Chi et al., 2010).”
BackgroundCopy Number Variations and Primary Open-Angle Glaucoma
Davis, L. K., Meyer, K. J., Schindler, E. I., Beck, J. S., Rudd, D. S., Grundstad, A. J., Scheetz, T. E., Braun, T. A., Fingert, J. H., Alward, W. L. M., et al. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-5606 · Cited by 42
The Role of Autophagy in Eye Diseases
Fernández‐Albarral, J. A., de Julián-López, E., Soler-Domínguez, C., de Hoz, R., López‐Cuenca, I., Salobrar‐García, E., Ramirez, J. M., Pinazo-Duran, M. D., Salazar, J. J., & Ramirez, A. I. (2021) · Life · doi:10.3390/life11030189 · Cited by 39
“In a study conducted on transgenic mice, overexpression of the most common mutation of the optineurin gene (OPTN E50K) was shown to cause a loss of retinal ganglion cells (RGCs) and other cell types [62,63].”
BackgroundA novel function of Huntingtin in the cilium and retinal ciliopathy in Huntington’s disease mice
Karam, A., Tebbe, L., Weber, C., Messaddeq, N., Morlé, L., Kessler, P., Wolfrum, U., & Trottier, Y. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.05.008 · Cited by 38
Reactive gliosis of astrocytes and Müller glial cells in retina of POMGnT1-deficient mice
Takahashi, H., Kanesaki, H., Igarashi, T., Kameya, S., Yamaki, K., Mizota, A., Kudō, A., Miyagoe‐Suzuki, Y., Takeda, S., & Takahashi, H. (2011) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2011.03.006 · Cited by 37
Autophagy in the eye: from physiology to pathophysiology
Liton, P. B., Boesze‐Battaglia, K., Boulton, M. E., Boya, P., Ferguson, T. A., Ganley, I. G., Kauppinen, A., Laurie, G. W., Mizushima, N., Morishita, H., et al. (2023) · Autophagy Reports · doi:10.1080/27694127.2023.2178996 · Cited by 37
Mi, X.-S., Zhang, X., Qian, F., Lo, A., Chung, S. K., & So, K. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-9999 · Cited by 36
Banton, M. C., Inder, K. L., Valk, E., Rudd, C. E., & Schneider, H. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01331-13 · Cited by 35
“GTP-bound Rab8 has been reported to bind to optineurin (57), MAP4K2 (52), FIP-2 (53), and rab8ip/GC kinase (52).”
Optineurin-facilitated axonal mitochondria delivery promotes neuroprotection and axon regeneration
Liu, D., Webber, H. C., Bian, F., Xu, Y., Prakash, M., Feng, X., Yang, M., Yang, H., You, I.-J., Li, L., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57135-8 · Cited by 34
“Because the glaucomatous neurodegeneration phenotypes of these mice are heterogenousandappearonlyataverylatestage(e.g.in12 – 18months old mice) 10,91,92 , however, they offered limited insights to the mechanisms of OPTN-induced neurodegeneration and limited opportunities to test potential…”
Hou, M., Shao, Z., Zhang, S., Liu, X., Fan, P., Jiang, M., Zhao, Y., Xiao, R., & Yuan, H. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04836-3 · Cited by 34
“Previous studies showed that transgenic animal models with different strategies presented independent retinal pathological phenotypes and visual dysfunction [14, 15].”
BackgroundChernyshova, K., Inoue, K., Yamashita, S., Fukuchi, T., & Kanki, T. (2019) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.19-27184 · Cited by 33
Familial normal tension glaucoma genetics
Fox, A. R., & Fingert, J. H. (2023) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2023.101191 · Cited by 33
Optineurin Functions for Optimal Immunity
Slowicka, K., & Loo, G. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00769 · Cited by 33
“The ALS-associated TBK1 E696K mutation specifically abolishes its binding to OPTN and disrupts OPTN/TBK1 complex formation (23, 34), this in contrast to the glaucoma-associated OPTN E50K mutation, shown to cause death of retinal ganglion cells in vitro and in transgenic mice (35), which enhances the interaction betwee…”
BackgroundMi, X.-S., Feng, Q., Lo, A. C. Y., Chang, R. C.-C., Chang, R. C., & So, K. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.284998 · Cited by 30
“1 mm on both sides of the optic nerve head (Chi et al., 2010) were analyzed using Stereo Investigator software (MBF Bioscience-MicroBrightField, Inc.”
InfluentialCrosstalk of Autophagy and the Secretory Pathway and Its Role in Diseases
Zahoor, M., & Farhan, H. (2018) · International review of cytology · doi:10.1016/bs.ircmb.2017.12.004 · Cited by 31
“Mutations of optineurin (in particular the E50K mutation) were shown to be associated with normal tension glaucoma and retinopathies (Rezaie et al, 2002; Chi et al, 2010).”
BackgroundThe Role of Mitophagy in Glaucomatous Neurodegeneration
Stavropoulos, D., Grewal, M. K., Petriti, B., Chau, K., Hammond, C. J., Garway‐Heath, D. F., & Lascaratos, G. (2023) · Cells · doi:10.3390/cells12151969 · Cited by 29
Nanotechnology and glaucoma: little particles for a big disease
Pita-Thomas, D. W., & Goldberg, J. L. (2013) · Current Opinion in Ophthalmology · doi:10.1097/icu.0b013e32835cfe92 · Cited by 29
“For example, research has demonstrated that mutations in the myocilin gene affect the function of trabecular meshwork cells [15], while mutations in the gene for optineurin make RGCs more susceptible to cellular damage and death [16].”
ResultLoss of Optineurin In Vivo Results in Elevated Cell Death and Alters Axonal Trafficking Dynamics
Paulus, J. D., & Link, B. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109922 · Cited by 29
“There have also been published reports using mouse transgenic lines where OPTN is overexpressed, resulting in progressive retinal degeneration [55,73].”
BackgroundThe Genetic and Endoplasmic Reticulum-Mediated Molecular Mechanisms of Primary Open-Angle Glaucoma
Rozpędek‐Kamińska, W., Wojtczak, R., Szaflik, J. P., Szaflik, J., & Majsterek, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114171 · Cited by 28
“It has also been demonstrated that OPTN E50K mutation-mediated glaucoma may be triggered via disruption of interaction between OPTN and Rab8 GTPase [146].”
BackgroundNeuroprotective Effects of Transferrin in Experimental Glaucoma Models
Youale, J., Bigot, K., Kodati, B., Jaworski, T., Fan, Y., Nsiah, N. Y., Pappenhagen, N., Inman, D. M., Béhar‐Cohen, F., Bordet, T., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112753 · Cited by 27
“Indeed, mutations in the optineurin (OPTN) gene have been identified as a causative factor for NTG [54,55], and were shown to induce a disruption in Rab8 and TF receptor 1 (TFR1) interaction leading to a defect in recycling of the TFR1/TF complex, which is essential for the control of iron levels [56,57].”
BackgroundGlaucoma Animal Models beyond Chronic IOP Increase
Tsai, T., Reinehr, S., Deppe, L., Strubbe, A., Kluge, N., Dick, H. B., & Joachim, S. C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020906 · Cited by 28
“The induced overexpression in E50K mice leads to glaucomatous-like damage without increased IOP, evidenced by an increased apoptosis rate leading to RGC loss and a reduction of the retinal thickness [53,54].”
BackgroundFunctional analysis of optineurin and some of its disease-associated mutants
Bansal, M., Swarup, G., & Balasubramanian, D. (2015) · IUBMB Life · doi:10.1002/iub.1355 · Cited by 27
“The transgenic mice expressing E50K-OPTN show activation of glial cells, which might contribute to glaucoma phenotype (loss of retinal cells) of these mice (43).”
BackgroundMeng, Q., Lv, J., Ge, H., Zhang, L., Xue, F., Zhu, Y., & Liu, P. (2012) · Molecular Biology Reports · doi:10.1007/s11033-011-1397-7 · Cited by 25
Swarup, G., & Nagabhushana, A. (2010) · Journal of Biosciences · doi:10.1007/s12038-010-0056-9 · Cited by 26
Proteomic analysis of aged and OPTN E50K retina in the development of normal tension glaucoma
Liu, X., Wang, Q., Shao, Z., Zhang, S., Hou, M., Jiang, M., Du, M., Li, J., & Yuan, H. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab099 · Cited by 25
The Role of MicroRNAs in Mitochondria-Mediated Eye Diseases
Carrella, S., Massa, F., & Indrieri, A. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.653522 · Cited by 25
“Moreover, mutations in OPTN encoding for the mitophagy adaptor protein optineurin (Rezaie et al., 2002; Wong and Holzbaur, 2014), TBK1 encoding the serine threonine protein kinase TANK-binding kinase 1 involved in autophagy (Sears et al., 2019), and OPA1 (Aung et al., 2002; Yu-Wai-Man et al., 2010; Guo et al., 2012) h…”
BackgroundWeil, R., Laplantine, E., & Génin, P. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.03.001 · Cited by 25
Axonal mitophagy in retinal ganglion cells
Yang, L., Li, Y., Jiao, Q., Wei, M., Wang, Y., Cui, A., Li, Z., & Li, G. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01761-0 · Cited by 22
“This mutation specifically triggers age-related loss of RGCs in transgenic mice, resulting in axonal degeneration and visual impairment [104, 105].”
BackgroundSayyad, Z., Kaveti, S., Bhattacharjee, D., Vedagiri, D., Jain, N., & Swarup, G. (2023) · FEBS Journal · doi:10.1111/febs.16739 · Cited by 22
LncRNAs in genetic basis of glaucoma
Cissé, Y., Bai, L., & Meng, T. (2018) · BMJ Open Ophthalmology · doi:10.1136/bmjophth-2017-000131 · Cited by 21
“OPTN mutations in transgenic mice models, including E50, have been identified as a key element in RGC apoptosis in previous studies; however, specific mechanisms remain largely unknown.(86) Recent studies have aimed to investigate the expression of differentially expressed lncRNAs in OPTN (E50K) transgenic and wild-ty…”
BackgroundThe diverse role of optineurin in pathogenesis of disease
Guo, Q., Wang, J., & Weng, Q. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114157 · Cited by 20
Shim, M. S., Kim, K.-Y., Noh, M., Ko, J. Y., Ahn, S., An, M. A., Iwata, T., Perkins, G. A., Weinreb, R. N., & Ju, W. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.08.025 · Cited by 20
“Recent studies, including those from our laboratory, have demonstrated that E50K mutation triggers not only age-related RGC loss but also photoreceptor cell degeneration, resulting in functional visual impairment in transgenic mice [12-15].”
BackgroundSelf-citationNormal-Tension Glaucoma and Potential Clinical Links to Alzheimer’s Disease
Ho, K., Bodi, N. E., & Sharma, T. P. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13071948 · Cited by 16
Metadata
- Authors
- Chi, Z.-L., Akahori, M., Obazawa, M., Minami, M., Noda, T., Nakaya, N., Tomarev, S., Kawase, K., Yamamoto, T., Noda, S., Sasaoka, M., Shimazaki, A., Takada, Y., & Iwata, T.
- Affiliations
- Tokyo Medical Center (JP)
- National Institutes of Health (US)
- Gifu University (JP)
- Tokai University (JP)
- Santen (Japan) (JP)
- Corresponding author
- Iwata, Takeshi
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-04-13
- Volume
- 19
- Issue
- 13
- Pages
- 2606-2615
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- PMC
- PMC2883340
- OpenAlex
- W2145273997
- Cited by
- 151
- References
- 41
- Citations by year
- 2026: 6 · 2025: 3 · 2024: 9 · 2023: 9 · 2022: 8 · 2021: 8 · 2020: 9 · 2019: 4 · 2018: 12 · 2017: 9 · 2016: 9 · 2015: 17 · 2014: 11 · 2013: 14 · 2012: 11
- FWCI
- 12.94
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Human Molecular Genetics (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology
- Topics
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Health Sciences › Medicine › Ophthalmology › Drug-Induced Ocular Toxicity
- Keywords
- optineurin, retinal degeneration, normal-tension glaucoma, primary open-angle glaucoma, retinal ganglion cell death, Golgi apparatus, vesicle trafficking, apoptosis, transgenic mouse model, optic nerve head
- MeSH terms
- Animals, Eye Proteins, Glaucoma, Mice, Inbred Strains, Mice, Transgenic, Optic Nerve, Protein Binding, Retinal Degeneration, Retinal Ganglion Cells, Apoptosis, Cell Cycle Proteins, Amino Acid Substitution, rab GTP-Binding Proteins, Membrane Transport Proteins, Mutant Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.